Technology-Enabled Intervention for Patients with Rare and Chronic Kidney Disease of Unknown Origin

George Institute for Global Health, India

Chronic Kidney Disease (CKD) is a significant public health challenge in India, associated with adverse health outcomes, poor health-related quality of life (HRQoL), and high healthcare costs. Population-based surveys estimate its prevalence at approximately 8% to 10%. CKD ranked as the 8th leading cause of death in India in 2016.  Worldwide, the burden of CKD is driven by the rising rates of diabetes and hypertension.

A mysterious and rare chronic kidney disease known as CKDu is affecting agricultural communities in parts of Central America, Sri Lanka, and India, particularly in Uddanam, a rural region of Andhra Pradesh. This disease, primarily affecting low-income populations, remains largely unexplained despite theories linking it to contaminated water and pesticides.  Uddanam, known for its lush greenery, has a population of 0.55 million across 326 villages and hamlets. There are eighteen primary healthcare facilities, seven secondary healthcare centres, five dialysis centres with one hundred forty dialysis units operating in three shifts daily, and a two hundred-bed kidney super speciality hospital and research centre. The George Institute for Global Health, in partnership with the Department of Health, operates a research centre at this hospital. Farming is the primary livelihood, with cashew nuts, coconut, and paddy as common crops. Unfortunately, the region struggles with poverty, low income, and limited education, hindering health awareness.

In 2018, George Institute, in support of Govt. of Andhra Pradesh and the Indian Council of Medical Research, conducted India’s first systematic estimation of the population-based prevalence of CKD in this Uddanam region. A cohort of 2419 participants from 118 villages across seven administrative regions (mandals) were recruited. These individuals underwent screening and subsequent repeat testing after a 3-month interval. Furthermore, they have been followed for 5 years. Our findings revealed an overall CKD prevalence of 21% in this population, with 15% meeting the CKDu case definition, which is 2.5 to 3.3 times higher than in other regions of India and with a crude death rate of ten times higher than national surveys. Additionally, over 90% of individuals with CKDu are unaware of their condition. The lack of awareness leads to CKD, causing 40% of adult fatalities in the area and incurs substantial healthcare expenses. Furthermore, we noted limited knowledge among primary and secondary care physicians regarding CKD management and a lack of access to evidence-based guidelines. Most patients had to travel over 150 kilometres to tertiary care centres in Vishakhapatnam for treatment, incurring substantial expenses and opportunity costs.

Primary healthcare physicians and frontline health workers, who serve as the initial point of contact in primary care units, often lack awareness of CKD's unique risk factors and have limited access to clinical guidelines for management. This leads to under recognition and undertreatment of CKD in primary care, resulting in low implementation of evidence-based interventions. Because early-stage CKD often shows no symptoms, screening high-risk individuals and implementing preventive measures are the most cost-effective strategies for detecting cases and halting disease progression in the Uddanam region. 

A lack of understanding of CKD risk factors and the failure to identify cases at early stages represent missed opportunities for early intervention to prevent the development or progression of kidney disease in the at-risk population of the Uddanam region. In this context, we suggest a digital health solution that has recently gained interest.

To improve the delivery of consistent, high-quality, essential primary healthcare to communities, George Institute has established a large program of research around understanding the prevalence and determinants of common NCDs in rural India and China and using that knowledge, developed a package of technology-enabled health system intervention to communities by using clinical decision support systems and task-shifting engaging frontline health workers. Initially designed to focus on cardiovascular disease, this digital platform (Systematic Medical Appraisal, Referral, and Treatment [SMART] Health) was subsequently adapted to provide care for people with mental health, diabetes, and kidney diseases. SMARThealth has now been tested in several healthcare systems, including Australia, Indonesia, Thailand, Myanmar, China, and India, and it shows promise in supporting preventive care at the community and household level by strengthening existing health systems. Based on our experience working with end-users, we believe that high-impact, essential CKD interventions (including detection, screening, treatment, and management) can be delivered through a primary healthcare model to strengthen early detection and timely treatment in this rural region of India.

The SMARThealth platform comprises five key elements. First, it includes an Android mobile platform used by frontline health workers for chronic disease screening, such as CKD, conducting risk assessments, and assisting with the prioritization of their work. Second, there is a corresponding web platform for doctors, powered by data entered by health workers during screenings and follow-ups. This platform provides real-time clinical decision support, based on Indian and international screening guidelines, which has been validated and field-tested. Third, the platform features a database/back-end system for storing patient data and other essential information, allowing for the synchronous or asynchronous processing of patient data securely sent to and accessed from a central server. Fourth, it integrates with other third-party systems through APIs (Application Programming Interface). Finally, the platform includes a web-based reporting and administrative system designed to manage multiple projects, utilizing shared resources and offering aggregated project metrics and analytics.

This solution is an excellent economic investment because, if implemented early, it can reduce the need for expensive treatment and significantly enhance the quality of life for patients and their health. To make this system more effective and enhance its prospects of achieving scalability, a transition to implementation at these communities is required.

Details on software and process are in this link: SMARThealth

Our solution targets multiple groups (a) vulnerable persons living with and at high risk of developing kidney disease, (b) primary healthcare physicians and (c) frontline health workers who are the first point of contact for healthcare in these communities. By implementing the SMARThealth platform, we aim to address several critical issues that currently contribute to the under recognition and undertreatment of CKD particularly the rare CKD of unknown origin in Uddanam:

Enhanced early detection and screening: The SMARThealth platform empowers frontline health workers with mobile tools to screen individuals for CKD and CKDu effectively. By conducting systematic screenings and risk assessments using clinical decision support systems, health workers can identify high-risk individuals early, even when the disease is asymptomatic. This early detection is crucial in preventing the progression of kidney disease and enabling timely intervention.

Improved access to clinical guidelines: The corresponding web platform for doctors, integrated with the mobile screening data, provides real-time clinical decision support. This support is based on validated Indian and international guidelines, ensuring that primary and secondary care physicians can access evidence-based practices for managing CKD. Consequently, this reduces the knowledge gap and improves the quality of care provided at the primary care level.

Localized and continuous care: The SMARThealth platform facilitates a continuum of care, from initial screening to ongoing management. Reducing the need for patients to travel long distances to tertiary care centres, significantly cuts down on healthcare expenses and opportunity costs. Patients receive consistent, high-quality care within their community, which enhances their health outcomes and quality of life.

Data-Driven Decision Making: The platform's backend database securely stores patient data, allowing for synchronous or asynchronous processing and real-time updates. This data can be used for monitoring and evaluation, helping healthcare providers to track disease patterns, measure the effectiveness of interventions, and make informed decisions. Additionally, integrating third-party systems through APIs ensures a comprehensive patient care and resource management approach.

Economic and Social Benefits: Early and accurate identification of CKD and CKDu, coupled with timely intervention, reduces the need for expensive treatments such as dialysis and transplantation. This is a significant economic benefit for a population with low per capita income. Furthermore, by improving health literacy and involving the community in their healthcare, the solution fosters a sense of empowerment and well-being among residents.

Scalability and Sustainability: The platform's modular design allows for scalability and adaptation to various healthcare settings. As the program grows, it can be extended to other regions with similar healthcare challenges, ensuring long-term sustainability and broader impact.

In summary, the SMARThealth platform serves the at-risk population of Uddanam by providing early detection, improved access to care, continuous localized support, and data-driven insights. By addressing the root causes of CKD under recognition and undertreatment, the solution has the potential to significantly improve health outcomes, reduce healthcare costs, and enhance the overall quality of life for this vulnerable population.

Since 2010, The George Institute has developed a program of work that uses an implementation science framework to improve the prevention and management of common chronic non-communicable diseases (NCDs) in primary health care (PHC) with a focus on rural communities. It is enabled by SMARThealth – a digital health platform for the Systematic Medical Appraisal, Referral and Treatment of common health conditions. The goal of SMARThealth is to strengthen health systems by overcoming fragmentation and promoting resource-sensitive, accessible, comprehensive and high-quality care. Depending on the context, SMARThealth has comprised a range of functions including:

• population enumeration and risk stratification
• community-based screening and referral
•  community-based health promotion and adherence support
• context-specific adaptive point-of-care clinical decision support for community health workers and doctors
• tools for care coordination, retention and follow-up
• health worker communication tools and online training
•  inventory management
• monitoring and analytics for a continuous quality improvement cycle

SMARThealth has been tested for a range of chronic conditions (cardiovascular diseases {CVD}), mental disorders, diabetes, kidney disease) in India, Indonesia, China, and Australia, including cluster randomised controlled trials (cRCTs) involving >120,000 participants.

In Indonesia, it has been adopted by the Malang District government for scale-up and integration with the electronic medical record system (e-puskesmas) in over 100 communities. The Indonesian Ministry of Health awarded the Malang District Government with the 2019 national Best Health Service Innovation award for the SMARThealth project, and it has been the subject of case studies of innovation for the World Bank and the WHO Southeast Asian Regional office. In Australia, it is being implemented nationally to over 150 Aboriginal Community Controlled Health Services in partnership with the country’s largest digital health provider, and in China it is being incorporated into a PHC strengthening strategy in partnership with the China Center for Disease Control.

In Indonesia, a quasi-experimental study involving 6,579 individuals at high risk of cardiovascular disease (CVD) was conducted across 8 villages. The intervention included community health worker screenings, doctor decision support, and a recall and reminder system, compared to usual care. The results showed a significant increase in the use of recommended medications (56.8% vs 15.7%), with an adjusted risk difference of 39.4% (95% CI, 37.0%-41.7%). Additionally, systolic blood pressure was 8.3 mmHg lower (95% CI, −10.1 to −6.6 mm Hg) in the intervention group. Due to its success, the program is now being expanded by the Malang District Health Agency to 100 communities.

In India, a stepped wedge cluster randomized controlled trial (cRCT) involving 62,254 individuals across 18 Primary Health Centres (PHCs) evaluated an intervention featuring ASHA screening, doctor decision support at Primary Health Care Centres, and a recall and reminder system compared to usual care. The study found no significant difference in blood pressure (BP) control rates between the intervention and control groups (41.2% vs 39.2%; Odds Ratio (OR): 1.01, 95% CI 0.76–1.35). However, there was a notable 22% improvement in the use of BP-lowering medications (54.3% vs 47.9%, OR 1.22, 95% CI 1.03–1.44).

In China, a cRCT involving 2,072 individuals with type 2 diabetes across 80 health centres implemented self-management support via a mobile application, peer support from family members, doctor decision support, and rewards with reminders compared to usual care. The intervention resulted in a 21% increase in combined control rates for HbA1C, blood pressure, and cholesterol (35.9% vs 29.9%; Risk Ratio (RR) 1.21, 95% CI 1.06–1.38) based on unpublished data.

In Australia, a cRCT with 38,275 participants across 60 primary health care services assessed point-of-care decision support and audit-feedback tools compared to usual care. The intervention showed a 25% improvement in appropriate cardiovascular disease (CVD) risk factor screening (RR 1.25, 95% CI 1.04–1.50) and a substantial 59% increase in the use of recommended medicines among under-treated individuals at high CVD risk (RR 1.59, 95% CI 1.19–2.13).

This program has already been implemented in India and 3 different countries.

Our solution is innovative because it leverages technology to address the multifaceted challenges of chronic kidney disease (CKD) and chronic kidney disease of unknown etiology (CKDu) in a resource-limited setting, which has thus far been neglected by the global health community. The SMARThealth platform stands out due to several key innovations:

Integration of Technology in Primary Care: The SMARThealth platform integrates advanced digital tools into the primary healthcare system, transforming how healthcare is delivered at the grassroots level. By equipping frontline health workers with an Android mobile platform, they can perform screenings, risk assessments, and data collection in real time. This technology-driven approach ensures that health workers can reach and effectively manage a larger segment of the population, particularly those in remote and rural areas.

Real-Time Clinical Decision Support: The platform provides a real-time clinical decision support system for doctors, based on validated Indian and international guidelines. This support ensures that healthcare providers at the primary and secondary care levels can make informed, evidence-based decisions. It bridges the knowledge gap and enhances the quality of care, ensuring that patients receive timely and appropriate interventions.

Impact on lives: The SMARThealth platform's implementation in the Uddanam region is anticipated to bring about transformative change by facilitating early detection and intervention, thereby mitigating the progression of CKDu. This proactive approach is expected to improve health outcomes, reduce mortality rates, and enhance the overall quality of care by providing real-time clinical decision support and evidence-based guidelines. By enabling early intervention and localized care, the platform aims to alleviate the financial burden associated with expensive treatments, benefiting both patients and the healthcare system. Moreover, community engagement and education initiatives integrated into the platform's framework will empower residents with enhanced health literacy, enabling them to make informed decisions about their well-being. The platform's modular design ensures scalability and sustainability, making it adaptable to other regions grappling with similar healthcare challenges. The incorporation of remote patient monitoring capabilities personalized digital interventions, and seamless data integration across the continuum of care positions the SMARThealth platform as a comprehensive solution to address the complex healthcare needs of the Uddanam region.

We're excited to submit for the Amgen Prize! Our technology-driven approach, SMARThealth, has the potential to completely transform the way chronic kidney disease (CKDu) is managed in underprivileged areas. But to expand SMARThealth and reach more people, there are obstacles. Overcoming these challenges would require financial backing. if given the funding, it will help us to expand our mobile health platform's infrastructure, train additional frontline healthcare workers, and tailor the program to address the unique needs of each region. The Amgen Prize would address more than just financial limitations. Additionally, it would give us the technical know-how to address important integration difficulties. As we expand SMARThealth, seamlessly linking it with various electronic medical record systems used across different healthcare settings is paramount. The Amgen Prize's resources would empower us to achieve this critical integration, ensuring smooth data exchange and enhanced patient care.

Furthermore, the Prize's acknowledgement would be transformational. Winning would confirm that SMARThealth is a successful CKDu management strategy. Undoubtedly, this esteemed acknowledgement would draw in new collaborators and provide opportunities to obtain supplementary funding. With the Amgen Prize's support, we envision a future where SMARThealth empowers countless communities struggling with CKDu, bringing them hope for improved health outcomes and a better quality of life.

Our team at the GIGH, India, is uniquely positioned to deliver the SMARThealth Pregnancy solution, leveraging our collective expertise, local connections, and commitment to addressing community health challenges.

Team Expertise and Leadership

Prof. Vivekananda Jha (VJ), Executive Director at the GIGH, India, is an expert on the health and societal impacts of non-communicable diseases (NCDs) through epidemiology and implementation science. His leadership in global nephrology networks and extensive research on chronic kidney disease, including environmental impacts, ensures our approach is scientifically robust and globally informed. As the Past-President of the International Society of Nephrology, he brings extensive global partnerships and networks to our project.

Dr. Devarasetty Praveen (DP), an expert in epidemiological study designs and implementation science, leads the SMARThealth program in India and Indonesia. His extensive experience in managing health system research projects across India, Sri Lanka, Indonesia, Bangladesh, and Thailand underscores his capability to manage large-scale health projects. As co-chair of the hypertension research program for the Global Alliance for Chronic Diseases, Praveen guides our study design, collaborations, and implementation, ensuring adherence to international standards and relevance to local contexts.

Dr. Balaji Gummidi (BG), a Public Health professional with a decade of experience, specializes in chronic kidney disease (CKDu) research. He has led projects on prevention, risk factors, and interventions in India, providing critical insights into addressing health issues in vulnerable communities.

Dr. Renu John (RJ), a Research Fellow at GIGH India, is involved in implementing the SMARThealth project in India. Her work in digital health interventions for NCDs, primary healthcare team integration, and lifestyle interventions for gestational diabetes ensures our solution is practical and effective in real-world settings.

Dr. Kavita Yadav (KY), with over a decade of experience in public health project implementation and management, leads qualitative and quantitative studies at the field level. She has been involved in the central coordination and implementation of research studies for CKDu in Andhra Pradesh and genomics studies, strengthening our capability to address complex health issues with innovative solutions.

Mrs. Sridevi Gara (SG), our technical lead, excels in aligning operations with IT systems. Her proficiency in AWS, containerization, and CI/CD processes is crucial for the deployment and maintenance of our AI chatbot, ensuring our digital solutions are technologically sound and scalable.

K Dilip Kumar (DK), a public health specialist with expertise in epidemiology and biostatistics, has published extensively on NCDs and health systems. His analytical skills and research background ensure our interventions are data-driven and evidence-based.

Our team members are deeply connected to the communities we serve. We have established and maintained strong partnerships with local stakeholders, including district officials, healthcare providers, and community health workers (ASHAs and ANMs). These relationships ensure our interventions are co-developed with input from those directly impacted, fostering local ownership and sustainability.

We aim to scale our solution across diverse states in India, leveraging our strong partnerships and robust technological framework. By continuously involving the community in design and implementation, ensuring our interventions are effective, culturally, and contextually-relevant.

Impact goals are concise statements of the specific external impact you wish to create through your solution. Your impact goals are what orient all aspects of your work. We look for solutions that will have a transformational impact on people’s lives. Use this space to describe your impact goals and how you plan to achieve them and measure progress along the way. Be sure to share a few specific indicators you are using to measure your progress.

Next Year (5-year goals):

1. Enhanced Health Equity and Well-being:

   • Increase the early detection rate of CKDu through proactive screening and awareness programs in rural areas of Srikakulam District.
   • Ensure 100% of rural households have access to screening for CKDu risk factors.

2. Research Capacity and Evidence Generation:

   • Publish 2 to 3 research findings in reputable peer-reviewed journals related to CKDu within the next 12 months.
   • Develop and submit initial policy recommendations based on research findings to government health ministries.

3. Innovation in Care Models:

   • Increase community and advocacy group participation in the development of care models by 10%.

4. Health, Societal, and Economic Impact:

   • Achieve a significant reduction in CKDu prevalence and associated health impacts across targeted rural populations in India.
   • Contribute to sustainable funding mechanisms for expanding research and implementing comprehensive primary healthcare initiatives addressing CKDu.

5. Policy Influence and System Strengthening:

   • Successfully advocate for the adoption of at least three to four policy recommendations at national and regional levels.

6. Scale-Up and Sustainability:

   • Scale up successful CKDu care models to additional districts or regions in India, supported by new funding opportunities.
   • Increase community and advocacy group representation in healthcare decision-making processes to 20%.

Measurement and Achievement Strategies:

Metrics and Measurement:

• Early Detection Rate: Measure the increase in the early detection rate of CKDu through regular screening programs and compare it against baseline data.
• Research Publications: Track the number of research papers published in reputable journals and their impact factors.
• Policy Recommendations: Monitor the submission and adoption of policy recommendations by government health ministries.
• Innovative Care Models: Evaluate the feasibility and effectiveness of care models through pilot studies and community feedback.
• Community Participation: Quantify the increase in community and advocacy group participation through surveys and engagement metrics.

Strategies to Achieve Goals:

• Collaborative Partnerships: Strengthen collaborations with national and state governments, community leaders, and healthcare providers to enhance program reach and effectiveness.
• Evidence-Based Interventions: Ensure all initiatives are grounded in robust research and evaluation to demonstrate impact and inform future strategies.
• Advocacy and Policy Influence: Engage actively in advocacy efforts to influence policy changes and secure sustainable funding for program expansion.
• Monitoring and Evaluation: Implement robust monitoring and evaluation frameworks to continuously assess progress towards goals and adapt strategies as needed.

By focusing on these impact goals and employing systematic measurement and achievement strategies, the program aims to make substantial contributions to CKDu management, healthcare system resilience, and policy improvements over the next one and five years.

Context and Problem Statement: Chronic Kidney Disease of unknown origin (CKDu) is a significant health challenge in rural areas, affecting a large number of community members. Current healthcare systems often lack adequate resources and guidelines tailored to manage CKDu effectively in these settings. There is a critical need to enhance healthcare capacity, improve management practices, and reduce health disparities related to CKDu.

The theory of change for SMARThealth is grounded in evidence-based practices, leveraging technology and capacity-building initiatives to address CKDu systematically. By implementing guidelines tailored to rural health settings and enhancing healthcare provider capabilities, the program ensures standardized, effective care delivery. Monitoring and evaluation mechanisms track progress towards health outcomes, ensuring continuous improvement and adaptation of strategies. Ultimately, the program aims to achieve sustainable impact by influencing policy and scaling successful interventions, thereby reducing the prevalence and impact of CKDu in rural India

Activities:

1. Development of Guidelines: Utilizing the SMARThealth data capture platform and clinical pathways, guidelines specific to CKDu management in rural health settings will be developed by a multidisciplinary team of healthcare experts.
2. Capacity Strengthening: Community health workers and clinical staff will be trained to co-design, implement, and communicate evidence-based practices for CKDu management using the developed guidelines.

Outputs:

• Guidelines for CKDu Management: By 12 months, finalized guidelines will outline standardized approaches for CKDu management, leveraging the SMARThealth platform to ensure consistency and effectiveness.
• Trained Healthcare Providers: Within 12 months, at least 80% of healthcare providers in rural areas will adopt evidence-based practices as per the guidelines, enhancing their capacity to manage CKDu.

Outcomes:

• Improved Adherence to Guidelines: Quarterly monitoring will track the percentage of rural health facilities adhering to CKDu management guidelines, aiming for at least 90% compliance. This ensures consistent and quality care delivery.
• Health Impact: Over 36 months, key health outcomes for CKDu patients, such as disease progression rates, hospitalization rates, and mortality rates, are targeted to reduce by 10%. This reduction reflects improved disease management and patient outcomes.

Impact:

• Community Health Improvement: Strengthening capacity among healthcare providers and improving adherence to evidence-based guidelines directly impacts CKDu patients, enhancing their quality of life and reducing the burden of disease within rural communities.
• Sustainability and Policy Influence: By demonstrating measurable improvements in health outcomes and healthcare delivery, the program aims to influence policy changes at national and regional levels, securing sustainable funding and expanding comprehensive CKDu management initiatives across the country.

Full-time staff

• Prof. Vivekananda Jha, Principles Investigator (PI)
• Dr. Devarasetty Praveen, Co-PI of Digital health in primary care
• Dr. Balaji Gummidi, Senior Project Manager Digital Health (DH) and NCD
• Dr. Renu John, Research Fellow in DH interventions
• Dr. Kavita Yadav, Research Fellow, Implementation science
• Dr Niveditha D, Program Lead, Data Management
• Mrs. Sridevi Gara, Technology Lead (SMARThealth)
• Mr Shajahan Basha, Senior PHP Developer
• K. Dilip Kumar, Research Assistant, NCD in primary health care
• Mr MV Satyanarayana, Program manager, NCD in primary Health care

Part-time staff:

• Nirosha Yeddalapudi, Junior Android Developer
• Murali Mohan, Field Supervisor

Overall, 12 members.

The George Institute has been using an implementation science approach since 2010 to improve how rural primary healthcare (PHC) manages and prevents common chronic diseases (NCDs). This approach is powered by SMARThealth, a digital health platform for systematic evaluation, referral, and treatment of common health conditions.

At GIGH, India, we prioritize diversity, inclusivity, and minimizing barriers to opportunity within our team, recognizing these values as fundamental to our mission and success. We actively seek to build a diverse team by recruiting individuals from various backgrounds, disciplines, and regions. Our recruitment process emphasizes equal opportunity and non-discrimination, ensuring candidates are assessed solely on their skills, experience, and potential contributions. This commitment to diversity extends beyond recruitment, as we foster a welcoming and inclusive environment by promoting a culture of respect, equity, and collaboration. Our workplace policies support inclusivity with flexible working hours, remote work options, and accommodations for employees with disabilities. We celebrate cultural diversity through various initiatives and events, recognizing and honoring different backgrounds and traditions.

To minimize barriers to opportunity, we provide continuous professional development and training programs tailored to the needs of our diverse staff. These programs include leadership training, skills development, and mentorship opportunities, enabling all team members to grow and advance in their careers. We support further education and research, empowering our staff to pursue their academic and professional goals. Our commitment to community representation is evident in our team composition, which includes members closely connected to the communities we serve. This proximity ensures that we remain attuned to the needs and challenges faced by these communities, allowing us to design and implement solutions that are culturally relevant and effective. By involving community representatives in our projects, we ensure that their voices and perspectives are integral to our work.

We maintain open channels for feedback and actively seek input from our team members on ways to improve our workplace environment. Our supportive policies, including those that support gender equality, parental leave, and anti-harassment measures, create a safe and supportive workplace for all. We are committed to providing equal opportunities for advancement and ensuring that all employees are treated with dignity and respect.

Our work, particularly in resource-limited settings like the Uddanam region, benefits significantly from our diverse team. By integrating advanced digital tools into primary care, we address complex health challenges such as chronic kidney disease (CKD) and chronic kidney disease of unknown etiology (CKDu). The SMARThealth platform exemplifies this innovation, leveraging technology to transform healthcare delivery at the grassroots level. Our inclusive approach ensures that we engage with and understand the unique needs of these communities, thereby enhancing the effectiveness and impact of our interventions. The platform's real-time clinical decision support and evidence-based guidelines empower healthcare providers to make informed decisions, improving health outcomes and reducing mortality rates.

In summary, our commitment to diversity, inclusivity, and minimizing barriers is a core aspect of our operational philosophy. By maintaining a diverse team and fostering an inclusive environment, we enhance our capacity to innovate and deliver impactful health solutions responsive to the communities' needs we serve. This holistic approach ensures that our interventions are not only effective but also equitable and sustainable, driving forward our mission to improve health outcomes in underserved populations.

Business Model

Value Proposition: The George Institute for Global Health provides value by delivering comprehensive, evidence-based solutions to improve kidney health among disadvantaged agricultural communities in Uddanam. Key beneficiaries include local healthcare providers, individuals at risk of CKD, and the broader community.

Products or Services Provided:

• Technology-Enabled Public Health Interventions: Utilization of the SMARThealth platform for early identification and management of CKD through data-driven clinical pathways and guidelines.
• Capacity Strengthening: Training programs and competency tests for healthcare professionals to enhance their knowledge and skills in CKD management and risk reduction.
• Community Engagement: Awareness campaigns and educational sessions to empower community members in recognizing and mitigating CKD risk factors.

Delivery Mechanism: Services are delivered through:

• Training Workshops: Conducted at local healthcare facilities to ensure hands-on learning and practical application of CKD management strategies.
• Technology Platform: Integrated into PHC systems to streamline data collection, patient management, and monitoring of CKD indicators.
• Community Outreach: Engaging local leaders and stakeholders to foster community participation and support for healthcare initiatives.

Why They Want or Need Them:

• Healthcare Providers: Seek improved knowledge and tools to effectively manage CKD cases and reduce disease burden.
• Community Members: Desire access to early detection, treatment, and education to prevent CKD progression and improve overall health outcomes.
• Government and Funders: Support initiatives that demonstrate measurable impact on public health and sustainable healthcare practices in underserved regions.

Outcome: By implementing this model, the George Institute for Global Health aims to achieve significant improvements in CKD management, reduce disease prevalence, and enhance overall health outcomes among vulnerable populations in Uddanam, Andhra Pradesh. This approach not only addresses immediate healthcare needs but also contributes to long-term sustainability and resilience of the healthcare system in combating CKD.

The George Institute for Global Health aims to achieve financial sustainability through a strategic approach combining diversified funding sources and evidence of impact to attract sustained support. Here’s our plan and evidence of success:

Plan for Financial Sustainability

1. Grant Funding: Continuously apply for competitive grants from international and national funding bodies, focusing on public health, non-communicable diseases (NCDs), and community health initiatives. These grants will support our research, program implementation, and capacity-building efforts, such as the SMARThealth program aimed at CKD management in Uddanam.
2. Philanthropic Donations: Cultivate relationships with philanthropic organizations and individual donors interested in healthcare, public health, and sustainable development. Develop tailored proposals showcasing our impactful interventions and outcomes to secure philanthropic support.
3. Consultancy Services: Offer consultancy services in public health research, program evaluation, and healthcare system strengthening to governments, NGOs, and healthcare institutions. Revenue generated from these services will supplement grant funding and philanthropic donations.
4. Publications and Intellectual Property: Publish research findings in reputable peer-reviewed journals and disseminate evidence-based guidelines and tools. Explore opportunities for licensing of intellectual property related to our technological innovations in healthcare delivery.
5. Partnerships and Collaborations: Forge strategic partnerships with academic institutions, governmental agencies, and private sector entities to leverage resources, expertise, and funding opportunities for joint initiatives in healthcare innovation and research.

 Evidence of Success

Grant Success: Secured competitive grants from prominent organizations such as:

1. The Chronic Kidney Disease of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium, funded by the National Institutes of Health (NIH).
2. STOP CKDu: Study to test & operationalize preventive approaches for CKDu in AP, funded by the Government of Andhra Pradesh, India
3. Heat Exposure and Environmental Action for Limiting the Burden of chronic kidney disease  of Undetermined Etiology in Andhra Pradesh: HEAL CKDu, funded by Dept. of Health Research and Ministry of Health and Family Welfare

Philanthropic Support: Received donations from philanthropic foundations such as HCL in the year (2018- 21) interested in advancing healthcare equity and reducing the burden of CKD in underserved communities. These funds have been pivotal in expanding our outreach and impact.

Publications and Impact Metrics: Published impactful research studies and guidelines that have influenced policy and practice in CKD management. These publications not only enhance our reputation but also attract further funding and partnership opportunities.

Long-Term Sustainability

Our revenue streams are designed to cover operational expenses and program costs, ensuring the long-term sustainability and scalability of our interventions. By demonstrating measurable impact, leveraging innovative technologies, and maintaining strong partnerships, we aim to continue securing funding and expanding our reach to benefit more communities affected by chronic kidney disease and other public health challenges.